C
CG Oncology D
D
CGON
56.130
USD
1.71
(3.14%)
مغلق
حجم التداول
41,422
الربح لكل سهم
-2
العائد الربحي
-
P/E
-24
حجم السوق
4,950,804,809
العنوان: CG Oncology
القطاع: Healthcare
الصناعة: Biotechnology
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer. The company's candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
